FLUIDIGM CORP (FLDM) Stock News

USA - NASDAQ:FLDM - Common Stock

3.71

-0.28 (-7.02%)

Last: 4/5/2022, 8:24:22 PM

4.02

+0.31 (+8.36%)

After Hours: 4/5/2022, 8:24:22 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FLDM Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: The Motley Fool - Mentions: SLGC

Why SomaLogic Stock Dived by 10% on Wednesday

2 years ago - By: Benzinga - Mentions: CEMI BRKR EXAS HOLX ...

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year

3 years ago - By: Benzinga - Mentions: BRKR EXAS HOLX OSUR ...

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests

4 years ago - By: Standard BioTools Inc. - Mentions: LAB

Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.

4 years ago - By: Standard BioTools Inc.

Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

4 years ago - By: Fluidigm Corporation

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

4 years ago - By: Fluidigm Corporation

Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution

4 years ago - By: Fluidigm Corporation

Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

4 years ago - By: Fluidigm Corporation

Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

4 years ago - By: Fluidigm Corporation

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

4 years ago - By: Fluidigm Corporation

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results

4 years ago - By: Fluidigm Corporation

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

4 years ago - By: Fluidigm Corporation

Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.

4 years ago - By: Molecular Stethoscope, Inc.

Molecular Stethoscope, Inc. establishes new Corporate Headquarters and Research & Development Laboratories in South San Francisco and appoints Gajus Worthington to its Board of Directors

4 years ago - By: Fluidigm Corporation

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

4 years ago - By: PennyStocks.com - Mentions: FB DXF GRNQ GLYC

Hot Penny Stocks To Buy Now? 4 To Add To Your List Today

4 years ago - By: Fluidigm Corporation

Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost

4 years ago - By: Fluidigm Corporation

Fluidigm Announces Third Quarter 2021 Financial Results

4 years ago - By: Fluidigm Corporation

Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer

4 years ago - By: Fluidigm Corporation

Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results

4 years ago - By: Fluidigm Corporation

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software

4 years ago - By: Barron's - Mentions: RUO INFN NPTN EGHT ...

This Fund Manager Loves Misunderstood Companies. Here Are His Favorite Stocks.

4 years ago - By: Barron's - Mentions: INFN NPTN EGHT ASPN ...

This Fund Manager Loves Growing but Misunderstood Companies. Here Are His Favorite Stocks.